![](https://investorshub.advfn.com/uicon/598979.png?cb=1658186434)
Tuesday, April 12, 2022 6:16:09 AM
Recent HOTH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:15:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:15:02 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 08:15:32 PM
- Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic • PR Newswire (US) • 08/15/2024 12:04:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:15:18 PM
- Micro Cap Already Off To The Races At The Bell • AllPennyStocks.com • 07/24/2024 02:30:00 PM
- Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment • PR Newswire (US) • 07/24/2024 10:30:00 AM
- Hoth Therapeutics Expands Clinical Trial for Cancer Patients • PR Newswire (US) • 07/16/2024 12:31:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 06/18/2024 10:15:38 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/18/2024 10:10:43 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/18/2024 10:07:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:41:10 PM
- Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery • PR Newswire (US) • 06/10/2024 12:11:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:00:56 PM
- Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 • PR Newswire (US) • 05/01/2024 12:00:00 PM
- Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds • PR Newswire (US) • 03/27/2024 06:00:00 PM
- Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment • PR Newswire (US) • 03/27/2024 12:27:00 PM
- Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ • PR Newswire (US) • 03/19/2024 12:21:00 PM
- Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio • PR Newswire (US) • 02/29/2024 01:38:00 PM
- Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic • PR Newswire (US) • 02/26/2024 01:11:00 PM
- Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024 • PR Newswire (US) • 02/13/2024 04:45:00 PM
- Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients • PR Newswire (US) • 01/18/2024 01:20:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM